Bonaventure Equity is raising $30 million to bet on life-science startups in the cannabis industry. A 'life sciences' approach to cannabisO'Brien says he broadly defines "life sciences" to encompass three different buckets: ag-tech, biotech, and healthcare. Investors poured $2.7 billion into cannabis startups in 2021, up from $1.5 billion in 2020, according to the data provider PitchBook. Bonaventure isn't the only venture firm focused on the life sciences aspect of cannabis. Óskare Capital, a new fund, is raising $170 million to invest in medical and pharmaceutical cannabis in Europe, as Insider has reported.

---